Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European stocks fall despite easing expectations; Dax down 0.06%

Published 05/28/2014, 03:40 AM
Updated 05/28/2014, 03:40 AM
European stocks slip lower despite ECB easing talk

Investing.com - European stocks fell on Wednesday, even as comments by European Central Bank President Mario Draghi on Tuesday fuelled expectations for further easing measures by the central bank.

During European morning trade, the DJ Euro Stoxx 50 fell 0.29%, France’s CAC 40 edged down 0.18%, while Germany’s DAX eased 0.06%.

On Tuesday, ECB President Mario Draghi said the bank was aware of the risks of persistently low inflation and was prepared to take steps to get euro zone inflation back to its target, the latest indication that the bank could ease monetary policy at its upcoming meeting next week.

The comments came a day after Draghi said the ECB is weighing a wide range of policy options, including interest rate cuts, and liquidity injections or broad-based asset purchases to help shore up the fragile recovery in the euro area.

Financial stocks were mixed, as BNP Paribas (PARIS:BNPP) slipped 0.13% and Societe Generale (PARIS:SOGN) rose 0.20% in France, while Germany's Deutsche Bank (XETRA:DBKGn) edged up 0.25%.

Among peripheral lenders, Italy's Unicredit (MILAN:CRDI) and Intesa Sanpaolo (MILAN:ISP) gained 0.20% and 0.70% respectively, while Spain's Banco Santander (MADRID:SAN) declined 0.40%.

Elsewhere, Nestle (SIX:NESN) saw shares gain 0.43% after the food company said it will expand its skincare unit in North America by paying $1.4 billion in cash for commercial rights to sell Valeant Pharmaceuticals (NYSE:VRX) products.

Hugo Boss (XETRA:BOSSn) slid lower on the other hand, down 0.39%, after its majority shareholder Permira Advisers LLP said it is selling 3.95 million shares in the German company at €101.25.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In London, FTSE 100 slipped 0.11%, weighed by losses in Glaxosmithkline (LONDON:GSK), down 1.35%, amid reports the drugmaker's "commercial practice" is under investigation by the U.K. Serious Fraud Office. The company has been accused in a number of countries of bribing government and hospital officials.

Mining stocks added to losses, as Glencore Xstrata (LONDON:GLEN) inched down 0.02% and Fresnillo (LONDON:FRES) edged 0.14% lower, while rivals Bhp Billiton (LONDON:BLT) and Rio Tinto (LONDON:RIO) slid 0.56% and 0.71% respectively.

Weir Group (LONDON:WEIR) was also on the downside, slipping 0.15%, after it abandoned its pursuit of Metso Oyj (HEL:MEO1V). The Finnish company's management turned down an all-share offer valuing the maker of mining and construction equipment at €4.6 billion euros.

Meanwhile, financial stocks were mixed. Shares in Lloyds Banking (LONDON:LLOY) dipped 0.01% and Barclays (LONDON:BARC) tumbled 1.10%, while the Royal Bank of Scotland (LONDON:RBS) gained 0.47% and HSBC Holdings (LONDON:HSBA) climbed 0.80%.

In the U.S., equity markets pointed to a steady open. The Dow 30 futures pointed to a 0.08% gain, S&P 500 futures signaled a 0.05% uptick, while the Nasdaq 100 futures indicated a 0.07% rise.

Latest comments

Referring to what is happening in the Wetern European markets, further companies will start listing at the Warsaw Stock Exchange (WSE) and the Polish stock will become more attractive to investors. Right now WSE retains its position as Europe's stock exchange attracting the highest number of debuts.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.